Abbott India reported its financial performance for the second quarter of FY25, showcasing solid growth in both revenue and net profit compared to the same period last year. However, the positive results were not enough to boost investor sentiment, leading to a decline in the company’s share price.
Financial Highlights
- Revenue from Operations: Abbott India recorded revenue from operations of ₹1,632.67 crore in Q2 FY25, representing a 9.3% increase from ₹1,494.14 crore in Q2 FY24. On a quarter-over-quarter (QoQ) basis, revenue rose by 4.8% from ₹1,557.61 crore in Q1 FY25.
- Profit Before Tax (PBT): The PBT for Q2 FY25 stood at ₹479.43 crore, reflecting a 15.4% year-over-year (YoY) increase from ₹415.42 crore in Q2 FY24. QoQ, PBT grew by 9.6% from ₹437.22 crore in Q1 FY25.
- Net Profit: The net profit for Q2 FY25 was ₹358.61 crore, marking a 14.6% YoY rise from ₹312.94 crore in Q2 FY24. On a QoQ basis, net profit increased by 9.3% from ₹328.01 crore in Q1 FY25.
Summary
Abbott India’s Q2 FY25 results demonstrated steady financial growth, yet the market reaction was lukewarm, possibly due to profit-taking or other external market factors. The company’s strong performance in revenue and profitability metrics did not prevent a dip in share price.
As of 1:58 pm, Abbott India shares were trading 3.22% lower at ₹28,207.20 on the NSE.
TOPICS:
Abbott India